Adjuvant Treatment for Older Women with Invasive Breast Cancer | Zendy

Trevor A. Jolly | Zendy; Grant R. Williams | Zendy; Sita Bushan | Zendy; Mackenzi Pergolotti | Zendy; Kirsten A. Nyrop | Zendy; Ellen L. Jones | Zendy; Hyman B. Muss | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Adjuvant Treatment for Older Women with Invasive Breast Cancer

Author(s) -

Trevor A. Jolly,

Grant R. Williams,

Sita Bushan,

Mackenzi Pergolotti,

Kirsten A. Nyrop,

Ellen L. Jones,

Hyman B. Muss

Publication year - 2016

Publication title -

women s health

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.363

H-Index - 39

eISSN - 1745-5065

pISSN - 1745-5057

DOI - 10.2217/whe.15.92

Subject(s) - medicine , breast cancer , life expectancy , adjuvant , incidence (geometry) , tamoxifen , gynecology , cancer , oncology , intensive care medicine , gerontology , population , physics , environmental health , optics

Older women experience a large share of breast cancer incidence and death. With the projected rise in the number of older cancer patients, adjuvant chemo-, radiation and endocrine therapy management will become a key component of breast cancer treatment in older women. Many factors influence adjuvant treatment decisions including patient preferences, life expectancy and tumor biology. Geriatric assessment predicts important outcomes, identifies key deficits, and can aid in the decision making process. This review utilizes clinical vignettes to illustrate core principles in adjuvant management of breast cancer in older women and suggests an approach incorporating life expectancy and geriatric assessment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research